Rakesh Kumar Singh - Search Results

Year	Number of Results
2004	1
2005	1
2006	2
2007	1
2008	2
2009	8
2010	4
2011	9
2012	10
2013	9
2014	6
2015	14
2016	9
2017	13
2018	6
2019	9
2020	12
2021	19
2022	22
2023	26
2024	19
2025	2

1

Singh RK. Singh RK. Natl J Maxillofac Surg. 2016 Jan-Jun;7(1):1-2. doi: 10.4103/0975-5950.196144. Natl J Maxillofac Surg. 2016. PMID: 28163470 Free PMC article. No abstract available.

2

Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy.

Kumari K, Singh A, Chaudhary A, Singh RK, Shanker A, Kumar V, Haque R. Kumari K, et al. Among authors: singh rk. Vaccines (Basel). 2024 May 5;12(5):498. doi: 10.3390/vaccines12050498. Vaccines (Basel). 2024. PMID: 38793749 Free PMC article. Review.

3

Malignant melanoma maxilla.

Devi S, Sinha R, Singh RK. Devi S, et al. Among authors: singh rk. Natl J Maxillofac Surg. 2015 Jan-Jun;6(1):115-8. doi: 10.4103/0975-5950.168216. Natl J Maxillofac Surg. 2015. PMID: 26668467 Free PMC article.

4

Editorial: Enhancing salinity tolerance in crops - molecular and practical perspectives.

Gautam RK, Singh RK, Krishnamurthy SL, Singla-Pareek SL. Gautam RK, et al. Among authors: singh rk. Front Plant Sci. 2024 Feb 14;15:1367677. doi: 10.3389/fpls.2024.1367677. eCollection 2024. Front Plant Sci. 2024. PMID: 38419776 Free PMC article. No abstract available.

5

The role of RIPK1 in chronic obstructive pulmonary disease.

Tiwari A, Gautam AS, Pandey SK, Singh S, Singh RK. Tiwari A, et al. Among authors: singh rk. Drug Discov Today. 2024 Jul;29(7):104020. doi: 10.1016/j.drudis.2024.104020. Epub 2024 May 11. Drug Discov Today. 2024. PMID: 38740363 Review.

6

Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders.

Goswami D, Anuradha U, Angati A, Kumari N, Singh RK. Goswami D, et al. Among authors: singh rk. CNS Neurol Disord Drug Targets. 2023;22(10):1403-1416. doi: 10.2174/1871527322666221128160653. CNS Neurol Disord Drug Targets. 2023. PMID: 36443979 Review.

7

Stokes holography.

Singh RK, Naik DN, Itou H, Miyamoto Y, Takeda M. Singh RK, et al. Opt Lett. 2012 Mar 1;37(5):966-8. doi: 10.1364/OL.37.000966. Opt Lett. 2012. PMID: 22378454

8

Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease.

Srivastava S, Rajopadhye R, Dey M, Singh RK. Srivastava S, et al. Among authors: singh rk. Expert Opin Ther Targets. 2021 Apr;25(4):243-247. doi: 10.1080/14728222.2021.1924151. Epub 2021 May 10. Expert Opin Ther Targets. 2021. PMID: 33909536 No abstract available.

9

Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease.

Pati S, Singh Gautam A, Dey M, Tiwari A, Kumar Singh R. Pati S, et al. Among authors: kumar singh r. Drug Discov Today. 2023 Dec;28(12):103750. doi: 10.1016/j.drudis.2023.103750. Epub 2023 Aug 24. Drug Discov Today. 2023. PMID: 37633326 Review.

10

Therapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation.

Singh Gautam A, Kumar Singh R. Singh Gautam A, et al. Among authors: kumar singh r. Drug Discov Today. 2023 Apr;28(4):103517. doi: 10.1016/j.drudis.2023.103517. Epub 2023 Feb 2. Drug Discov Today. 2023. PMID: 36736763 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year